Urologic Oncology: Seminars and Original Investigations
Publisher: Elsevier · ISSN 1078-1439 · 64 articles
- Transitioning from template-based groin dissection to dynamic sentinel node biopsy in penile cancer: Prospective validation of a standardization step
- Comparing patient-reported urinary and sexual bother and function after robotic-assisted radical prostatectomy
- Prospectively collected functional vs. self-reported frailty measures and postoperative outcomes after radical cystectomy in older adults with bladder cancer
- Restricted mean survival time-based network meta-analysis of first-line therapies for metastatic clear cell renal cell carcinoma
- Project international Delphi consensus recommendations for perioperative management of inguinal lymphadenectomy in cancer patients
- Incidence and predictors of prolonged opioid use following nephrectomy for renal cell carcinoma: A national claims-based study
- Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study
- Overview of the genetic pathogenesis of penile cancer
- Multi-omics profiling of FFPE tissues identifies serine synthesis and impaired creatine metabolism as metabolic hallmarks of high-grade bladder cancer
- The role of circulating gene variants in penile carcinoma
- Diagnostic value of CEUS-VI-RADS for predicting muscle invasion in bladder cancer: Validation of the scoring system and introduction of tumor-bladder wall contact length as a supplementary quantitative metric
- Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysis
- Efficacy and safety analysis of disitamab vedotin combined with immunotherapy as neoadjuvant treatment to promote conversion to bladder preservation in bladder cancer: A retrospective comparative study with the GC combined with immunotherapy regimen
- Postoperative progression-free survival and clinicopathological risk stratification in urachal carcinoma: A multicenter retrospective cohort study
- The AURKA–PTTG1 signaling axis induces enzalutamide resistance in prostate cancer
- Prehabilitation for patients undergoing radical cystectomy: Patient selection and targeted interventions
- Association of robot-assisted radical prostatectomy with improved oncological outcomes in patients with oligometastatic prostate cancer: A multicenter exploratory study in China
- Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma
- Serum Galectin-3 as a complementary biomarker in non-muscle-invasive bladder cancer
- Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer
- Real-world ctDNA test utilization and associated costs in US patients with bladder cancer who underwent radical cystectomy
- Molecular profiling of renal mass biopsy tissue: A review of feasibility and clinical utility
- Adoption and perceptions of utility of the RENAL nephrometry score among fellowship-trained urologic oncologists in North America
- Adherence to active surveillance monitoring among Medicare beneficiaries with prostate cancer
- PCOLCE2 inhibits BLCA progression via ACSL6-dependent ferroptosis and its transcription is suppressed by the BDH1-H3K9bhb axis
- Retraction notice to “Combination Chemotherapy with Docetaxel, Estramustine and Suramin for Hormone Refractory Prostate Cancer” [Urologic Oncology: Seminars and Original Investigations 23 (2005) 93–101]
- Retraction notice to “Safety and Efficacy Of Sorafenib In Patients With Castrate Resistant Prostate Cancer: A Phase II Study” [Urologic Oncology: Seminars and Original Investigations 28 (2010) 21–27]
- Retraction notice to “Opium Consumption and Risk of Bladder Cancer: A Case-Control Analysis” Urologic Oncology: Seminars and Original Investigations 28 (2010) 610–616
- Comparison of novel salvage therapies for BCG-unresponsive NMIBC against gemcitabine/docetaxel: A reconstructed individual patient data analysis
- Nanoparticle delivery of phytochemicals and dietary factors for epigenetic modulation in prostate cancer